Needham & Company Reiterates a 'Buy' on Measurement Specialties (MEAS); Tempered F2Q Results & Outlook, But Recent Acquisitions Should Provide Support
Tweet Send to a FriendGet Alerts MEAS Hot Sheet
Price: $46.19 -1.16%
Rating Summary:
0 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Rating Summary:
0 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Trade MEAS Now!
Needham & Company reiterates a 'Buy' on Measurement Specialties (NASDAQ: MEAS) price target of $33.00.
Needham analyst says, "While the macro sluggishness and uncertainty is tempering organic biz order flow from customers, recent strategic acquisitions (and diverse wins) should help provide balance with only a slightly reduced outlook in aggregate. We believe recent acquisitions of Celesco and Gentech enhance the model as well as the strategic product roadmap that should help
drive longer-term growth. Overall, we still believe MEAS has a high degree of visibility in its business, and we remain positive on prospects."
"Adjusting Estimates. Our F3Q estimates become $79M in revs., $14.2M EBITDA, and $0.39, vs. prior $77.0M, $15.5M, and $0.48. F12 now $313M in revs, $58.8M EBITDA, & $1.82 (EPS lower largely due to taxes & amort), vs. prior $308M, $61.7M EBITDA, & $1.94."
For more ratings news on Measurement Specialties click here and for the rating history of Measurement Specialties click here.
Shares of Measurement Specialties closed at $28.21 yesterday, with a 52 week range of $22.40-$38.98.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Needham analyst says, "While the macro sluggishness and uncertainty is tempering organic biz order flow from customers, recent strategic acquisitions (and diverse wins) should help provide balance with only a slightly reduced outlook in aggregate. We believe recent acquisitions of Celesco and Gentech enhance the model as well as the strategic product roadmap that should help
drive longer-term growth. Overall, we still believe MEAS has a high degree of visibility in its business, and we remain positive on prospects."
"Adjusting Estimates. Our F3Q estimates become $79M in revs., $14.2M EBITDA, and $0.39, vs. prior $77.0M, $15.5M, and $0.48. F12 now $313M in revs, $58.8M EBITDA, & $1.82 (EPS lower largely due to taxes & amort), vs. prior $308M, $61.7M EBITDA, & $1.94."
For more ratings news on Measurement Specialties click here and for the rating history of Measurement Specialties click here.
Shares of Measurement Specialties closed at $28.21 yesterday, with a 52 week range of $22.40-$38.98.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
- Wells Fargo Downgrades Brinker Int'l (EAT) to Market Perform
- Wells Fargo Downgrades Ruby Tuesday (RT) to Market Perform
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Needham & Company
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
